한국의 두통 연구에 관해 몇 가지 말씀해 주시겠습니까?

이미지 교수는 한국 의사들이 구조적 및 기능적 연결성 연구를 포함하여, 두통 병태생리, 진단, 치료의 다양한 측면에 대한 연구를 활발히 하고 있다고 말합니다. 한국 의사들은 또한 두통 질환의 다기관 등록을 통해 협력하고 있습니다.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

한국에서의 편두통 치료 개선을 위해 어떤 변화가 도움이 되겠습니까?

이미지 교수는 편두통 및 관련 장애에 대한 더 큰 인식이 한국에서 필요하다고 제안하며, 편두통 전문가가 충분하지 않은 상황에서 더 많은 비전문가 의사들이 편두통 환자들을 돌보는데 관심을 가지기를 희망합니다.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

Can you tell us about some of the headache research in Korea?

Korean physicians are active in research into many aspects of headache pathophysiology, diagnosis and treatment, including structural and functional connectivity studies, says Dr Mi Ji Lee. They are also collaborating through a multi-centre registry of headache disorders.

 


LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

What changes would help to improve migraine care in Korea?

Dr Mi Ji Lee suggests that greater awareness of migraine and its associated disability are needed in Korea and, in the absence of sufficient migraine experts, she hopes that more non-specialist doctors will become interested in caring for patients with the condition.

 


LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

What advice would you give doctors about using migraine therapies?

Dr Mi Ji Lee advises physicians treating patients with migraine to go back to basic principles, especially in difficult-to-treat patients, and discusses a flexible approach to treatment duration with CGRP monoclonal antibodies.

 


LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

한국에서 편두통은 얼마나 흔합니까?

한국 내 편두통의 엄밀한 유병률은 약 6%이고 개연 편두통 유병률은 12%로 전체 유병률은 북미 및 유럽과 비슷합니다. 한국의 편두통 역학이 몇몇 다른 나라들과 차이를 보이는 가능성 있는 이유들에 대해 이미지 교수가 논의합니다.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

한국에서 편두통 진단은 어떻게 합니까?

한국은 잘 정립된 1차, 2차, 3차 진료 서비스를 갖추고 있지만 환자들은 편두통 진단을 받기까지 수 년을 기다려야만 할 수도 있습니다. 이미지 교수는 대중의 오해와 국제적 분류와 비교했을 때 핵심 증상의 차이가 이에 일조한다고 설명합니다.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

한국에는 어떤 편두통 치료법이 있습니까?

한국에서의 편두통 급성기 및 예방 치료를 위한 다양한 치료법과 국민건강보험 프로그램을 통한 칼시토닌 유전자 관련 펩타이드 단클론항체 (CGRP mAb)의 일부 급여에 대한 엄격한 자격 기준에 대해 이미지 교수가 설명합니다.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

항CGRP 치료법은 한국에서의 연구와 임상 진료에서 얼마나 효과가 있었습니까?

한국 내 여러 센터가 CGRP 단클론항체에 대한 국제적 및 지역 임상 시험에 참여했으며, 한국 의사들도 실제 임상 연구를 수행했습니다. 도출된 결과들과 그 결과들이 임상의들과 환자들에게 의미하는 바에 대해 이미지 교수가 살펴봅니다.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

How effective have anti-CGRP therapies been in Korean studies and in clinical practice?

Several centres in Korea took part in international and regional clinical trials of CGRP monoclonal antibodies, and Korean physicians have also carried out real world studies. Dr Mi Ji Lee takes a look at the results and what they mean for clinicians and patients.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

Which migraine therapies are available in Korea?

Dr Mi Ji Lee describes the range of therapies available for acute and preventive treatment of migraine in Korea and the strict eligibility criteria for partial reimbursement of CGRP monoclonal antibodies through the national insurance programme.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

How is migraine diagnosed in Korea?

Korea has well defined primary, secondary and tertiary care services but patients can wait years for a migraine diagnosis. Dr Mi Ji Lee explains that public misunderstandings and differences in core symptoms compared to international classifications play a part.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.


 

How common is migraine in Korea

Strict prevalence of migraine in Korea is about 6% and probable migraine prevalence is 12% - bringing overall prevalence close to that in North America and Europe. Dr Mi Ji Lee discusses possible reasons why migraine epidemiology in Korea is different from some other countries.

 

LundbeckThis educational activity is supported by an educational grant from H. Lundbeck A/S, who has had no influence on or input into the development or the performance of the educational activity.